The report on global diabetic
neuropathy market provides qualitative and quantitative analysis for the period
of 2017 to 2023. According to the report the global diabetic neuropathy market is, growing with a CAGR between 5.0 % to 5.5 % from 2017 to 2023. The global diabetic neuropathy market size was totaled 3.58 billion in 2016.
1: Global Diabetic Neuropathy
Market by Value 2015 - 2023
Growth in global diabetic neuropathy market is highly attributed to consistently increasing diabetic population
across the globe linked with growing awareness among people is considered as
major market driver for diabetic neuropathy market. Moreover, global market is
primarily driven by changing lifestyle which has mostly resulted into unhealthy
dietary habits and patterns. In addition, factors such as increasing aging
population, rise in healthcare expenditure for diabetes, growing awareness
about diabetes, and rise in R&D activities in drug discovery and
development have contributed in the global growth. However, growth of this
market is predominantly restrained by longer approval time for drugs and side
effects and rising cost of diabetic neuropathy treatment. Also, stringent
regulatory requirement and significant failure rate during the clinical trials
expected to be the growth barriers in the years to come.
On account of increasing diabetes
cases worldwide, rapid product launches and increasing mergers and acquisition,
global diabetic neuropathy market will have massive growth opportunities.
Rising cost of diabetic neuropathy treatment expected to remain as challenge in
front of this market throughout the forecast period.
The report segments the global diabetic neuropathy market by disorder type, by treatment type, by
distribution channel by region. The market size of each segment has been
provided in terms of value (USD). Based on disorder type, global market has
been divided into peripheral neuropathy, autonomic neuropathy, proximal
neuropathy, and focal neuropathy. market segmentation based on the treatment
type includes drugs, Radiotherapy, and physiotherapy. Moreover, Drugs further
sub-segmented into analgesic, antidepressant, and anticonvulsants. Moreover, on
the basis of distribution channel market segmented into hospitals, clinics,
retails pharmacy, and online pharmacy
Coverage and Analysis:
The report provides regional analysis covering
geographies such as North America, Europe, Asia-Pacific, and Rest of the World.
In this section the key trends and market size for each geography is provided
over the period of 2017 – 2023.
2: Global Diabetic Neuropathy
Market by Region 2015 - 2023
America is the largest market for diabetic neuropathy globally, with over 35%
of global market shares followed by Europe. Growth in this region is attributed
to increasing numbers of diabetic cases linked with rising awareness among
people about diabetes and related complication, and significant rise in
research and development activities. Increasing diabetes rate in this region
has surged growth for diabetic neuropathy in North America region. Furthermore,
US and Canada are the major markets in this region and has played major role in
the regional growth. Following North America, Europe is the second largest
market for diabetic neuropathy. Asia Pacific, however, is the emerging market
anticipated to grow at highest growth rate over the forecast period. This is
due to increasing government support in the form of funding, developing healthcare
infrastructure across the region and economic development in this region.
Moreover, India is one of the dynamic markets in APAC region projected to
contribute significantly in regional growth.
The companies covered in the
report include Pfizer Inc,
Janssen Pharmaceuticals, Inc, Eli Lilly and Company, ACTAVIS, Cephalon Inc,
MEDA Pharma GmBH & Co. KG, GlaxoSmithKline, NeuroMetrix, Inc, and Johnson
The report provides deep
insights on demand forecasts, market trends and micro and macro indicators. In
addition, this report provides insights on the factors that are driving and
restraining the demand of diabetic neuropathy globally as well as regionally. Moreover, IGR-Growth
Matrix analysis given in the report brings an insight on the investment areas
that existing or new market players can consider.
The report provides insights
into the market using analytical tools such as Porter’s five forces analysis
and DRO analysis of diabetic
neuropathy. Moreover, the study highlights current market trends
and provides forecast from 2017 to 2023. We also have highlighted future trends
in the diabetic neuropathy Market
that will impact the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight on the
market share of the leading players. Additionally, the analysis highlights rise
and fall in the market shares of the key players in the market.
This report will help
manufacturers, suppliers and distributors of the diabetic neuropathy Market to understand the
present and future trends in this market and formulate their strategies